Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD
AERD 中 E 类前列腺素受体信号传导缺陷的机制和后果
基本信息
- 批准号:8915315
- 负责人:
- 金额:$ 14.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAgonistAllergensAllergicAnimal ModelArachidonate 5-LipoxygenaseArachidonic AcidsAspirinAsthmaAvidityBindingBlood PlateletsBlood specimenBreathingBronchoconstrictionCellsCharacteristicsCyclic AMPDefectDinoprostoneDiseaseDisease modelDoseEP4 receptorEffector CellEnzymesEpigenetic ProcessForced expiratory volume functionFrequenciesFunctional disorderGenerationsHomeostasisImmune responseIn VitroIndividualInflammationIntegrinsLeukocytesLeukotriene A4Leukotriene C4Leukotriene E4LeukotrienesLinkLungLung diseasesMediatingMediator of activation proteinMessenger RNAOrganP-SelectinParentsPathogenesisPathway interactionsPhasePlatelet ActivationPlayPneumoniaProductionProstaglandin E ReceptorProstaglandinsProteinsReceptor SignalingRelative (related person)RoleSELP geneSamplingSignal TransductionTestingTherapeuticTissuesVascular remodelingbasecysteinyl leukotriene receptorcysteinyl-leukotrieneeosinophilepigenetic variationgranulocytein vitro activityin vivomRNA Expressionneutrophilnovelperipheral bloodpreventprostaglandin EP2 receptorreceptorreceptor couplingreceptor expressionreceptor functionrespiratoryresponseurinary
项目摘要
This project tests the hypotheses that deficient EP2 receptor expression and function in platelets and
leukocytes alters homeostasis of the adenylyl cyclase/cyclic adenosine monophosphate (cAMP) pathway as
a disease-causing mechanism in aspirin exacerbated respiratory disease (AERD). Platelets are required for
granulocyte recruitment in animal models of pulmonary inflammation, binding to leukocytes via P-selectin
(CD62P) and facilitating integrin avidity. When bound to neutrophils, platelets can also form leukotriene
(LT)C4 (the parent of the cysteinly leukotrienes (cys-LTs)) from neutrophil-derived LTA4. We have
discovered that platelets from subjects with aspirin exacerbated respiratory disease (AERD) are markedly
deficient in expression of the Gs-linked EP2 receptor for PGE2 relative to platelets from normal and aspirin-tolerant
asthmatic (ATA) controls. As a result, neither exogenous PGE2 nor a selective EP2 agonist can
block activation of platelets from individuals with AERD in vitro, or the formation of platelet-leukocyte
aggregates. Moreover, peripheral blood samples from individuals with AERD contain several fold higher
frequencies of platelet-leukocyte aggregates than do samples from normal and aspirin-tolerant ATA controls,
suggesting a functional result of diminished EP2 signaling in vivo that could enhance both tissue
inflammation and the generation of cys-LTs. Furthermore, the defect in EP2 receptor expression extends to
peripheral blood leukocytes from individuals with AERD, accompanied by concomitantly defective expression
of mRNA encoding EP4 receptors; both defects are reversed by aspirin treatment. Aim 1 is to determine the
consequences of defects in the function of the EP2 subtype of prostaglandin E2 receptor on platelets in the
pathophysiology of AERD. Aim 2 is to determine the consequences of deficient of EP2 and EP4 receptor
signaling on 5-lipoxygenase (5-LO) pathway activity in peripheral blood leukocytes and whether the
deficiency is corrected by treatment with aspirin. Aim 3 is to characterize the extent of epigenetic variation in
EP receptors, classical and novel CysLTRs, and associated candidate effectors in AERD.
该项目测试血小板中 EP2 受体表达和功能缺陷的假设
白细胞改变腺苷酸环化酶/环磷酸腺苷 (cAMP) 途径的稳态
阿司匹林加剧呼吸道疾病(AERD)的致病机制。需要血小板
肺部炎症动物模型中粒细胞的募集,通过 P-选择素与白细胞结合
(CD62P) 并促进整合素亲和力。当与中性粒细胞结合时,血小板也可以形成白三烯
(LT)C4(半胱氨酸白三烯 (cys-LTs) 的母体)来自中性粒细胞衍生的 LTA4。我们有
发现患有阿司匹林加剧呼吸系统疾病(AERD)的受试者的血小板显着降低
相对于正常和阿司匹林耐受的血小板,PGE2 的 Gs 连接 EP2 受体的表达存在缺陷
哮喘(ATA)控制。因此,外源性 PGE2 和选择性 EP2 激动剂都不能
体外阻断 AERD 患者血小板的激活,或血小板白细胞的形成
聚合体。此外,AERD 患者的外周血样本中含有数倍的
血小板-白细胞聚集的频率比正常和阿司匹林耐受 ATA 对照样品的频率高,
表明体内 EP2 信号减弱的功能结果可以增强两种组织
炎症和 cys-LT 的产生。此外,EP2受体表达的缺陷延伸至
来自 AERD 患者的外周血白细胞,同时伴有表达缺陷
编码EP4受体的mRNA;这两种缺陷都可以通过阿司匹林治疗来逆转。目标 1 是确定
前列腺素 E2 受体 EP2 亚型功能缺陷对血小板的影响
AERD 的病理生理学。目标 2 是确定 EP2 和 EP4 受体缺乏的后果
外周血白细胞中 5-脂氧合酶 (5-LO) 通路活性的信号传导以及是否
缺陷可以通过阿司匹林治疗来纠正。目标 3 是表征表观遗传变异的程度
EP 受体、经典和新型 CysLTR 以及 AERD 中的相关候选效应器。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua A Boyce其他文献
Joshua A Boyce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua A Boyce', 18)}}的其他基金
Control of Pulmonary Inflammation by Leukotriene E4
白三烯 E4 控制肺部炎症
- 批准号:
10666460 - 财政年份:2021
- 资助金额:
$ 14.81万 - 项目类别:
Control of Pulmonary Inflammation by Leukotriene E4
白三烯 E4 控制肺部炎症
- 批准号:
10468771 - 财政年份:2021
- 资助金额:
$ 14.81万 - 项目类别:
Control of Pulmonary Inflammation by Leukotriene E4
白三烯 E4 控制肺部炎症
- 批准号:
10666460 - 财政年份:2021
- 资助金额:
$ 14.81万 - 项目类别:
Control of Pulmonary Inflammation by Leukotriene E4
白三烯 E4 控制肺部炎症
- 批准号:
10296403 - 财政年份:2021
- 资助金额:
$ 14.81万 - 项目类别:
Influence of NSAIDs and AERD on the expression and function of ACE2 - implications for SARS-CoV2 severity
NSAID 和 AERD 对 ACE2 表达和功能的影响 - 对 SARS-CoV2 严重程度的影响
- 批准号:
10197400 - 财政年份:2020
- 资助金额:
$ 14.81万 - 项目类别:
CysLT and P2Y Receptors in Lung Inflammation
肺部炎症中的 CysLT 和 P2Y 受体
- 批准号:
10321255 - 财政年份:2018
- 资助金额:
$ 14.81万 - 项目类别:
CysLT and P2Y Receptors in Lung Inflammation
肺部炎症中的 CysLT 和 P2Y 受体
- 批准号:
10083690 - 财政年份:2018
- 资助金额:
$ 14.81万 - 项目类别:
Eicosanoid Networks in Aspirin Hypersensitivity
阿司匹林过敏中的类二十烷酸网络
- 批准号:
10517922 - 财政年份:2017
- 资助金额:
$ 14.81万 - 项目类别:
Eicosanoid Networks in Aspirin Hypersensitivity
阿司匹林过敏中的类二十烷酸网络
- 批准号:
10296672 - 财政年份:2017
- 资助金额:
$ 14.81万 - 项目类别:
Eicosanoid Networks in Aspirin Hypersensitivity
阿司匹林过敏中的类二十烷酸网络
- 批准号:
10062848 - 财政年份:2017
- 资助金额:
$ 14.81万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水体中β2-肾上腺素受体激动剂(PPCPs)间接光降解机理的量子化学与实验研究
- 批准号:22306084
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV4/SKCa信号轴在AMPK激动剂抑制微小动脉舒张作用中的机制研究
- 批准号:82304584
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于纳米铝乳剂和模式识别受体激动剂的复合型佐剂研究
- 批准号:82341043
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
相似海外基金
Mechanism and Function of Beta-2 Adrenergic Receptor Degradation in the Lung
肺内β2肾上腺素受体降解的机制和功能
- 批准号:
8455125 - 财政年份:2013
- 资助金额:
$ 14.81万 - 项目类别:
Mechanism and Function of Beta-2 Adrenergic Receptor Degradation in the Lung
肺内β2肾上腺素受体降解的机制和功能
- 批准号:
8701380 - 财政年份:2013
- 资助金额:
$ 14.81万 - 项目类别:
Mechanism and Function of Beta-2 Adrenergic Receptor Degradation in the Lung
肺内β2肾上腺素受体降解的机制和功能
- 批准号:
9102236 - 财政年份:2013
- 资助金额:
$ 14.81万 - 项目类别:
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD
AERD 中 E 类前列腺素受体信号传导缺陷的机制和后果
- 批准号:
8195747 - 财政年份:2011
- 资助金额:
$ 14.81万 - 项目类别:
Regulation of Pulmonary Prostaglandins by Leukotriene E4
白三烯 E4 对肺前列腺素的调节
- 批准号:
7737735 - 财政年份:2009
- 资助金额:
$ 14.81万 - 项目类别: